ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company

ProteoNic Biotechnology BV has announced that it licensed its 2G UNic technology for boosting recombinant protein produc...

February 5, 2019 | Tuesday | News
CIRM approves $6M to study new treatment for Huntington's disease

Following a California Institute for Regenerative Medicine (CIRM) Independent Citizens Oversight Committee meeting held ...

February 5, 2019 | Tuesday | News
OmniVision develops innovative smart dental mirror

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, along with SMARTmirror, a deve...

February 5, 2019 | Tuesday | News
Senseonics extends distribution agreement with Roche

Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, impla...

February 5, 2019 | Tuesday | News
IQVIA to develop solutions for life sciences industry

IQVIA has announced the launch of IQVIA Biotech and its new approach to delivering tailored clinical and commercial solu...

February 5, 2019 | Tuesday | News
Torque collaborates with Thermo Fisher for immunotherapy facility

Torque, an immuno-oncology company developing first-in-class Deep Primed T Cell Therapeutics to direct immune power deep...

February 5, 2019 | Tuesday | News
Fortress Biotech announces strategic partnership with Alexion Pharma

Biopharma company, Fortress Biotech dedicated to acquiring, developing and commercializing novel pharmaceutical and biot...

February 4, 2019 | Monday | News
Health systems must provide cancer screening, detection and diagnosis at all levels of care

Cancer is far from an equal-opportunity killer. In 2018 - 18.1 million new cases developed worldwide, while around 9.6 m...

February 4, 2019 | Monday | Opinion
Alkermes announces rejection of ALKS 5461 NDA

Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration ...

February 4, 2019 | Monday | News
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval

Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmetero...

February 1, 2019 | Friday | News
Magnolia Medical announces $20M funding

Magnolia Medical Technologies has announced a $20 million Series C financing round to scale the company’s infrastr...

February 1, 2019 | Friday | News
J&J collaborates with MeiraGTx

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced a worldwide collaboration and license agreem...

February 1, 2019 | Friday | News
FDA expands Lilly's ALIMTA Label

Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed...

February 1, 2019 | Friday | News
I Holland to conduct seminar on problems in tablet production

I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets is pleased...

January 31, 2019 | Thursday | News
Spero Therapeutics announces initiation of SPR720 Ph 1 Clinical Trial

Spero Therapeutics,  a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...

January 31, 2019 | Thursday | News
Aldeyra Therapeutics acquires Helio Vision

Aldeyra Therapeutics, a biotechnology company developing and commercializing next-generation medicines for immune-mediat...

January 31, 2019 | Thursday | News
Medtronic announces launch of Mazor X Stealth

Ireland based Medtronic has announced the first U.S. patients treated with the Mazor X Stealth(TM) Edition for spine sur...

January 31, 2019 | Thursday | News
Livongo to acquire myStrength

Applied Health Signals company, Livongo Health has announced that it has signed a definitive agreement to acquire Denver...

January 31, 2019 | Thursday | News